221 related articles for article (PubMed ID: 32917965)
1. An algorithm to quantify intratumor heterogeneity based on alterations of gene expression profiles.
Li M; Zhang Z; Li L; Wang X
Commun Biol; 2020 Sep; 3(1):505. PubMed ID: 32917965
[TBL] [Abstract][Full Text] [Related]
2. DEPTH2: an mRNA-based algorithm to evaluate intratumor heterogeneity without reference to normal controls.
Song D; Wang X
J Transl Med; 2022 Apr; 20(1):150. PubMed ID: 35365157
[TBL] [Abstract][Full Text] [Related]
3. DITHER: an algorithm for Defining IntraTumor Heterogeneity based on EntRopy.
Li L; Chen C; Wang X
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34096997
[TBL] [Abstract][Full Text] [Related]
4. Defining multiple layers of intratumor heterogeneity based on variations of perturbations in multi-omics profiling.
Ai H; Song D; Wang X
Comput Biol Med; 2023 Jun; 159():106964. PubMed ID: 37099972
[TBL] [Abstract][Full Text] [Related]
5. SpliceHetero: An information theoretic approach for measuring spliceomic intratumor heterogeneity from bulk tumor RNA-seq.
Kim M; Lee S; Lim S; Kim S
PLoS One; 2019; 14(10):e0223520. PubMed ID: 31644551
[TBL] [Abstract][Full Text] [Related]
6. A clonal expression biomarker associates with lung cancer mortality.
Biswas D; Birkbak NJ; Rosenthal R; Hiley CT; Lim EL; Papp K; Boeing S; Krzystanek M; Djureinovic D; La Fleur L; Greco M; Döme B; Fillinger J; Brunnström H; Wu Y; Moore DA; Skrzypski M; Abbosh C; Litchfield K; Al Bakir M; Watkins TBK; Veeriah S; Wilson GA; Jamal-Hanjani M; Moldvay J; Botling J; Chinnaiyan AM; Micke P; Hackshaw A; Bartek J; Csabai I; Szallasi Z; Herrero J; McGranahan N; Swanton C;
Nat Med; 2019 Oct; 25(10):1540-1548. PubMed ID: 31591602
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma.
Hua X; Zhao W; Pesatori AC; Consonni D; Caporaso NE; Zhang T; Zhu B; Wang M; Jones K; Hicks B; Song L; Sampson J; Wedge DC; Shi J; Landi MT
Nat Commun; 2020 May; 11(1):2459. PubMed ID: 32424208
[TBL] [Abstract][Full Text] [Related]
8. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity.
Andor N; Graham TA; Jansen M; Xia LC; Aktipis CA; Petritsch C; Ji HP; Maley CC
Nat Med; 2016 Jan; 22(1):105-13. PubMed ID: 26618723
[TBL] [Abstract][Full Text] [Related]
9. Measuring intratumor heterogeneity by network entropy using RNA-seq data.
Park Y; Lim S; Nam JW; Kim S
Sci Rep; 2016 Nov; 6():37767. PubMed ID: 27883053
[TBL] [Abstract][Full Text] [Related]
10. Subtyping of Human Papillomavirus-Positive Cervical Cancers Based on the Expression Profiles of 50 Genes.
Zhu X; Li S; Luo J; Ying X; Li Z; Wang Y; Zhang M; Zhang T; Jiang P; Wang X
Front Immunol; 2022; 13():801639. PubMed ID: 35126391
[TBL] [Abstract][Full Text] [Related]
11. Turning the headlights on novel cancer biomarkers: Inspection of mechanics underlying intratumor heterogeneity.
McBride M; Rida PC; Aneja R
Mol Aspects Med; 2015 Nov; 45():3-13. PubMed ID: 26024970
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal copy number heterogeneity predicts survival rates across cancers.
van Dijk E; van den Bosch T; Lenos KJ; El Makrini K; Nijman LE; van Essen HFB; Lansu N; Boekhout M; Hageman JH; Fitzgerald RC; Punt CJA; Tuynman JB; Snippert HJG; Kops GJPL; Medema JP; Ylstra B; Vermeulen L; Miedema DM
Nat Commun; 2021 May; 12(1):3188. PubMed ID: 34045449
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer.
Ma D; Jiang YZ; Liu XY; Liu YR; Shao ZM
Breast Cancer Res Treat; 2017 Feb; 162(1):39-48. PubMed ID: 28093659
[TBL] [Abstract][Full Text] [Related]
14. Intratumor heterogeneity predicts metastasis of triple-negative breast cancer.
Yang F; Wang Y; Li Q; Cao L; Sun Z; Jin J; Fang H; Zhu A; Li Y; Zhang W; Wang Y; Xie H; Gustafsson JÅ; Wang S; Guan X
Carcinogenesis; 2017 Sep; 38(9):900-909. PubMed ID: 28911002
[TBL] [Abstract][Full Text] [Related]
15. Identification of prostate cancer subtypes based on immune signature scores in bulk and single-cell transcriptomes.
Chen C; Luo J; Wang X
Med Oncol; 2022 Jun; 39(9):123. PubMed ID: 35716212
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation intratumor heterogeneity in localized lung adenocarcinomas.
Quek K; Li J; Estecio M; Zhang J; Fujimoto J; Roarty E; Little L; Chow CW; Song X; Behrens C; Chen T; William WN; Swisher S; Heymach J; Wistuba I; Zhang J; Futreal A; Zhang J
Oncotarget; 2017 Mar; 8(13):21994-22002. PubMed ID: 28423542
[TBL] [Abstract][Full Text] [Related]
17. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
[TBL] [Abstract][Full Text] [Related]
18. Intratumor Heterogeneity and Antitumor Immunity Shape One Another Bidirectionally.
Wolf Y; Samuels Y
Clin Cancer Res; 2022 Jul; 28(14):2994-3001. PubMed ID: 35380639
[TBL] [Abstract][Full Text] [Related]
19. Subtyping of sarcomas based on pathway enrichment scores in bulk and single cell transcriptomes.
Li S; Liu Q; Zhou H; Lu H; Wang X
J Transl Med; 2022 Jan; 20(1):48. PubMed ID: 35093080
[TBL] [Abstract][Full Text] [Related]
20. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
